Traws Pharma, Inc. (TRAW): Operating Cash Flow
-$18.18M
Year ended 2025-12-31
-$16.85M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$18.18M | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$29.79M | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$17.93M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$16.29M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$19.49M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$23.07M | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$20.83M | n/m | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | -$22.70M | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$23.82M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$15.81M | n/m | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | -$31.24M | n/m | 2017-03-29, From 2015-01-01 |
| 2014-12-31 | -$57.65M | n/m | 2016-03-28, From 2014-01-01 |
| 2013-12-31 | -$61.38M | n/m | 2015-03-30, From 2013-01-01 |
| 2012-12-31 | $1.63M | n/m | 2015-03-30, From 2012-01-01 |
| 2011-12-31 | -$14.17M | n/a | 2014-03-20, From 2011-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | -$18.18M | n/m |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | -$9.48M | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$18.64M | n/m |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | -$15.68M | n/m |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | -$4.83M | n/m |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | -$4.66M | n/m |
| Genprex, Inc. (GNPX) | 2025-12-31 | -$15.31M | n/m |
| MetaVia Inc. (MTVA) | 2025-12-31 | -$15.70M | n/m |
| Oragenics Inc (OGEN) | 2025-12-31 | -$9.25M | n/m |
Compare TRAW, SHPH, LGVN, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗